Next 10 |
home / stock / envb / envb articles
Enveric Biosciences (NASDAQ:ENVB) reported it financial results on Wednesday for the first quarter of 2024 ended March 31, 2024. "We believe the fi...
Psychedelics biotech firm, Enveric Biosciences (NASDAQ:ENVB) has signed a non-binding term sheet to out-license a class of Novel Psilocin Prodru...
Enveric Biosciences (NASDAQ:ENVB), a Nasdaq-listed psychedelics biotech firm, has entered into a non-binding term sheet with an undisclosed biotech...
Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter EPS...
U.S. stocks traded mixed this morning, with the Nasdaq Composite falling around 100 points on Tuesday. Following the market opening Tuesday, the Do...
Enveric Biosciences (NASDAQ:ENVB) shares are trading higher after the company signed two non-binding term sheets with an undisclosed biotechno...
U.S. stocks traded mixed toward the end of trading, with the S&P 500 gaining around 0.3% on Thursday. The Dow traded down 0.08% to 38,919.26 wh...
Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter fin...
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 100 points on Thursday. The Dow traded down 0.16% to 38,8...
News, Short Squeeze, Breakout and More Instantly...
Enveric Biosciences Inc Com Company Name:
ENVB Stock Symbol:
NASDAQ Market:
1.57% G/L:
$1.25 Last:
63,207 Volume:
$1.25 Open:
$1.25 Close:
Enveric Biosciences Inc Com Website:
urban-gro Inc. (UGRO) is expected to report for quarter end 2025-03-31 Karman Holdings Inc. (KRMN) is expected to report $0.02 for Q1 2025 PyroGenesis Inc Com (PYRGF) is expected to report for quarter end 2025-03-31 GeoVax Labs Inc. (GOVX) is expected to report $-0.59 for Q1 2025 ...
Vivos Inc (RDGL) is expected to report for quarter end 2024-12-31 Nickel Creek Platinum Corp (NCPCF) is expected to report for quarter end 2024-12-31 ViewBix Inc (VBIXD) is expected to report for quarter end 2024-12-31 Forte Biosciences Inc. (FBRX) is expected to report $-4.55 for Q4 ...
2025-02-26 11:47:42 ET Enveric Biosciences, Inc. (NASDAQ: ENVB) is one of today’s top gainers. The company’s shares have moved 102.12% on the day to $2.38. Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for canc...